Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Didier Raoult and Yanis Roussel.
Didier Raoult
Connection Strength
2.950
Yanis Roussel
  1. Be Careful With Big Data: Reanalysis of Patient Characteristics and Outcomes of 11 721 Patients With Coronavirus Disease 2019 Hospitalized Across the United States. Clin Infect Dis. 2021 06 01; 72(11):e928.
    View in: PubMed
    Score: 0.948
  2. SARS-CoV-2: fear versus data. Int J Antimicrob Agents. 2020 May; 55(5):105947.
    View in: PubMed
    Score: 0.873
  3. Effect of hydroxychloroquine and azithromycin on SARS-CoV-2 clearance in COVID-19 patients, a meta-analysis. Int J Antimicrob Agents. 2021 Jan; 57(1):106240.
    View in: PubMed
    Score: 0.230
  4. Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature. Int J Antimicrob Agents. 2021 01; 57(1):106241.
    View in: PubMed
    Score: 0.230
  5. Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al. Clin Microbiol Infect. 2021 01; 27(1):132-133.
    View in: PubMed
    Score: 0.226
  6. Chloroquine and COVID-19: A western medical and scientific drift? Eur J Intern Med. 2020 08; 78:4-5.
    View in: PubMed
    Score: 0.222
  7. Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. 2020 May - Jun; 35:101738.
    View in: PubMed
    Score: 0.220
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.